<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="156531">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02087592</url>
  </required_header>
  <id_info>
    <org_study_id>LIBRE-F-110013</org_study_id>
    <nct_id>NCT02087592</nct_id>
  </id_info>
  <brief_title>Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers</brief_title>
  <acronym>LIBRE</acronym>
  <official_title>Prospective Randomized Multicenter Trial to Assess the Feasibility of a Structured Physical Exercise Training and Mediterranean-style Diet in Women With BRCA1/2 Mutations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität München</source>
  <oversight_info>
    <authority>Germany: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      BRCA1/2 mutation carriers have a considerably increased risk to develop breast and ovarian
      cancer during their lifetime. There is evidence from the literature that for sporadic breast
      cancer disease risk and the course of disease can be significantly influenced by physical
      activity, nutrition and weight. The hypothesis of this 3 year, prospective randomized
      multicenter feasibility trial is that a structured life-style intervention program with
      exercise training and mediterranean diet is feasible and improves the nutritional and
      fitness status as well as the weight, the quality of life and stress reacting capacity.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Number of patients successfully completing the intervention program</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stress coping capacity (TICS)</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grade of optimism (LOT)</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index as a marker of caloric balance</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total fat intake</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maximum exercise capacity (VO2max) as a marker of physical fitness</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (SF-36)</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity (IPAQ questionnaire)</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Anthropometric parameters (waist and hip circumference, skinfold measurements)</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Body composition (body impedance analysis)</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Eating behaviour</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Laboratory parameters</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Aerobic exercise capacity during ergometry</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hereditary Breast and Ovarian Cancer</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual standard of care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Usual standard of care plus structured physical exercise training plus mediterranean-style diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Structured exercise training plus mediterranean diet</intervention_name>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women with proven pathogenic BRCA1/2 mutation

        Exclusion Criteria:

          -  metastatic tumor disease

          -  life expectancy &lt;3 years

          -  clinically limiting cardiovascular or respiratory disease

          -  significant orthopedic disability which prevents from participating in the exercise
             training

          -  severe concomitant disease which prevents from participating in the group
             interventions

          -  Karnofsky index &lt;60

          -  VO2max &gt;150%

          -  Maximal exercise capacity &lt; 50 W

          -  food allergies which prevent from mediterranean diet

          -  vegan diet

          -  body mass index &lt;15 kg/m2

          -  pregnancy

          -  insufficient knowledge of German language

          -  insufficient compliance

          -  active participation in other interventional trials

          -  no informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marion Kiechle, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Technische Universität München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Halle, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Technische Universität München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephan C Bischoff, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Universitaet Hohenheim, Stuttgart</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wolf-Dieter Gerber, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Universitaetsklinikum Schleswig-Holstein, Campus Kiel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markus Loeffler, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>University of Leipzig</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christoph Engel, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>University of Leipzig</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rita K Schmutzler, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>University of Cologne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alfons Meindl, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Technische Universität München</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marion Kiechle, Prof. Dr.</last_name>
    <phone>+49 89 4140 2420</phone>
    <email>marion.kiechle@lrz.tu-muenchen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sabine Brandhorst</last_name>
    <phone>+49 89 4140 2433</phone>
    <email>Sabine.Brandhorst@mri.tum.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Cologne</name>
      <address>
        <city>Cologne</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Rita K Schmutzler, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Schleswig-Holstein Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Wolf-Dieter Gerber, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Technische Universitaet Muenchen</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Marion Kiechle, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.frauenklinik.med.tum.de/</url>
  </link>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 13, 2014</lastchanged_date>
  <firstreceived_date>March 12, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hereditary breast and ovarian cancer (HBOC)</keyword>
  <keyword>BRCA1/2 mutation carriers</keyword>
  <keyword>Mediterranean diet</keyword>
  <keyword>Structured exercise training</keyword>
  <keyword>prevention</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
